Mustafa, Sally
Bougie, Joanna
Miguelez, Maia
Clerzius, Guerline
Rampakakis, Emmanouil
Proulx, Jean
Malla, Ashok
Funding for this research was provided by:
Lundbeck Canada Inc (NCT02131415)
Otsuka Canada Pharmaceutical Inc (NCT02131415)
Article History
Received: 23 November 2018
Accepted: 4 April 2019
First Online: 16 April 2019
Ethics approval and consent to participate
: All patients signed an informed consent before any study related procedures were performed. Central Ethics approval was obtained from IRB Services, Aurora, Ontario, Canada. In addition, approval from local institutional ethics boards (University of Windsor, McGill University Health Centre, Institut Universitaire en Santé Mentale de Québec, Capital Health, Ottawa Health Science Network, Royal Ottawa Health Care Group, University of Calgary, Western University, Queen’s University, Douglas Mental Health University Institute, University of British Columbia) was obtained as required.
: Not applicable.
: Dr. Malla is personally supported by Canada Research Chairs program. He was not involved in patient recruitment or in clinical care of the patients who participated in this study. In addition, to research funding from peer reviewed granting agencies, he reports research funding for an investigator-initiated project (2011–2014), unrelated to the present study report, from BMS Canada; honoraria for lectures delivered at conferences and for consultations on research sponsored by Otsuka and Lundbeck, Canada and Global and consulting activities with Otsuka and Lundbeck. Sally Mustafa was supported by a grant from Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc. Joanna Bougie, Guerline Clerzius and Jean Proulx are employees of Lundbeck Canada. Maia Miguelez is an employee of Otsuka Canada Pharmaceutical. Emmanouil Rampakakis is an employee of JSS Medical Research, the contract research organization mandated to manage the study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.